Skip to content
CMS overreach will impede innovation
In implementing the Inflation Reduction Act (IRA), the Centers for Medicare and Medicaid Services (CMS) has made efforts to unnecessarily broaden the law with […]
CMS overreach will impede innovation Read More »
Setting the record straight on accelerated approval
Is the accelerated approval pathway helping patients achieve better health outcomes or imposing on society medicines that don’t work? In BIO’s view, the pathway
Setting the record straight on accelerated approval Read More »
Sanders launches politically motivated investigation into revolutionary, cost-effective diabetes and obesity medicines
Sen. Bernie Sanders (I-Vt.), Chair of the Senate Health, Education, Labor, and Pensions Committee, announced that he is launching an investigation into the pricing
Heart disease patients and the IRA’s misguided incentives
The Inflation Reduction Act (IRA) is expected to have broad negative impacts on patients, most notably through less access to future cures and treatments.
Heart disease patients and the IRA’s misguided incentives Read More »
Key takeaways from the State of the Union address
President Biden delivered his third State of the Union address last night, March 7. Health care was a prominent theme throughout the night, which
Key takeaways from the State of the Union address Read More »
As White House prepares ‘listening session’ on PBMs, here’s what they need to hear
On Monday, March 4, the White House will host a “listening session” on the impact of Pharmacy Benefit Managers (PBMs). This is a welcome
As White House prepares ‘listening session’ on PBMs, here’s what they need to hear Read More »